BR112021023757A2 - Uso de espectrometria de massa para identificar tecido de endometriose - Google Patents

Uso de espectrometria de massa para identificar tecido de endometriose

Info

Publication number
BR112021023757A2
BR112021023757A2 BR112021023757A BR112021023757A BR112021023757A2 BR 112021023757 A2 BR112021023757 A2 BR 112021023757A2 BR 112021023757 A BR112021023757 A BR 112021023757A BR 112021023757 A BR112021023757 A BR 112021023757A BR 112021023757 A2 BR112021023757 A2 BR 112021023757A2
Authority
BR
Brazil
Prior art keywords
mass spectrometry
identify
tissue
endometriosis
tissue site
Prior art date
Application number
BR112021023757A
Other languages
English (en)
Inventor
L Feider Clara
Jialing Zhang
John Lin
Schiavinato Eberlin Livia
T Breen Michael
Thomas Milner
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of BR112021023757A2 publication Critical patent/BR112021023757A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00—Chemical aspects of mass spectrometric analysis of biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Primary Health Care (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Endocrinology (AREA)
  • Software Systems (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Bioethics (AREA)

Abstract

uso de espectrometria de massa para identificar tecido de endometriose. em um aspecto geral, métodos e dispositivos são fornecidos para o uso de espectrometria de massa para identificar endometriose. em alguns aspectos, um volume fixo ou distinto de um solvente é aplicado a um local de tecido, incluindo possível tecido de endometriose. o solvente aplicado é coletado para obter uma amostra líquida. a amostra de líquido é submetida à análise de espectrometria de massa. a amostra de líquido é coletada de um local de tecido in vivo durante um procedimento médico. os dados de espectrometria de massa são analisados para identificar se o local do tecido compreende endometriose.
BR112021023757A 2019-06-06 2020-06-05 Uso de espectrometria de massa para identificar tecido de endometriose BR112021023757A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962858300P 2019-06-06 2019-06-06
PCT/US2020/036351 WO2020247769A2 (en) 2019-06-06 2020-06-05 Using mass spectrometry to identify endometriosis tissue

Publications (1)

Publication Number Publication Date
BR112021023757A2 true BR112021023757A2 (pt) 2022-02-01

Family

ID=73652294

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021023757A BR112021023757A2 (pt) 2019-06-06 2020-06-05 Uso de espectrometria de massa para identificar tecido de endometriose

Country Status (11)

Country Link
US (1) US20220268784A1 (pt)
EP (1) EP3980778A4 (pt)
JP (1) JP2022535404A (pt)
KR (1) KR20220018564A (pt)
CN (1) CN114008455A (pt)
AU (1) AU2020288649A1 (pt)
BR (1) BR112021023757A2 (pt)
CA (1) CA3142727A1 (pt)
IL (1) IL288411A (pt)
MX (1) MX2021014945A (pt)
WO (1) WO2020247769A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3176883A1 (en) * 2020-04-27 2021-11-04 Board Of Regents, The University Of Texas System Detecting chemical compounds for forensic analysis
WO2023170045A1 (en) * 2022-03-07 2023-09-14 Univerza V Ljubljani Method for diagnosing endometriosis in a subject

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6840935B2 (en) * 2000-08-09 2005-01-11 Bekl Corporation Gynecological ablation procedure and system using an ablation needle
US8444591B2 (en) * 2009-10-09 2013-05-21 John Temple Insufflation gas heater system and tubing for use therewith
US9216037B2 (en) * 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US20150185238A1 (en) * 2012-05-31 2015-07-02 Helmholtz Zentrum Munchen Novel method for the diagnosis of endometriosis
WO2014121262A2 (en) * 2013-02-04 2014-08-07 Children's National Medical Center Hybrid control surgical robotic system
IL265129B2 (en) 2016-09-02 2024-02-01 Univ Texas Collection sensor and methods of using it

Also Published As

Publication number Publication date
IL288411A (en) 2022-01-01
MX2021014945A (es) 2022-04-06
CA3142727A1 (en) 2020-12-10
EP3980778A2 (en) 2022-04-13
US20220268784A1 (en) 2022-08-25
AU2020288649A1 (en) 2021-12-16
WO2020247769A2 (en) 2020-12-10
CN114008455A (zh) 2022-02-01
WO2020247769A3 (en) 2021-01-14
EP3980778A4 (en) 2023-05-10
KR20220018564A (ko) 2022-02-15
JP2022535404A (ja) 2022-08-08

Similar Documents

Publication Publication Date Title
BR112021023757A2 (pt) Uso de espectrometria de massa para identificar tecido de endometriose
AR112132A1 (es) Sistema de pruebas universal para análisis cuantitativo
CL2018002308A1 (es) Método y aparato para medir la concentración de sustancias objetivo en la sangre.
EP4357784A3 (en) Collection probe and methods for the use thereof
BR112015019614A8 (pt) análise de imagens e medições de amostras biológicas
WO2007002579A3 (en) Assay cartridges and methods for point of care instruments
BRPI0508515B8 (pt) dispositivo de amostragem de fluido corpóreo
DK1585444T3 (da) Apparat til optagelse af en kropsvæske til analyseformål
DE60325180D1 (de) Mikrovorrichtungen zur untersuchung von biologischen systemen
MX2020005448A (es) Sonda de recoleccion minimamente invasiva y metodos para el uso de esta.
NO20053170L (no) Fremgangsmate for a forhindre gjenbruk i et analyttmalesystem.
ATE538809T1 (de) Verfahren zur auswahl von geeigneten patienten für den wt1-impfstoff
WO2014190052A3 (en) Self-serve kiosk for blood/fluid/tissue collection and screening
BR112015026222A2 (pt) dispositivo de coleta de amostra de fluido biológico
CY1118544T1 (el) Προσδιορισμος ολικου αιματος
UY37960A (es) Sistemas y procedimientos para el cribado de laboratorio de muestras biológicas
MX2019010223A (es) Sistema de gestion de enfermedad interdisciplinar.
SG11201900972UA (en) Health-level measuring method, health-level determining apparatus, and hair-health examination system
BR112015030378A2 (pt) sistema e métodos para avaliar fluxo sanguíneo periférico durante procedimentos de intervenção vascular periférica e interface de paciente
DE602004000200D1 (de) Vorrichtung zur Analyse der Zyklus/Zyklus-Alternanz und/oder der Variabilität der ventrikulären Repolarisierungswelle eines EKG-Signals
WO2018045208A8 (en) Collection probe and methods for the use thereof
RU2015108014A (ru) Системы и способы минимально инвазивного измерения газов в артериальной крови
EA201650035A1 (ru) Пробирный анализ для определения антикоагулянтов в крови или в плазме крови
DK3568696T3 (da) Koaguleringsbegrænsningsprobe til blodanalyseinstrument
BR102015015096A2 (pt) método de detecção in vitro de câncer de tireoide em um paciente, método in vitro de diferenciação entre câncer de tireoide e tecido de tireoide normal ou de lesões benignas de tireoide, uso de um conjunto de genes, método de obtenção de dados para direcionamento do tratamento do cancer de tireoide, kit laboratorial e dispositivo para classificar uma amostra biológica de glândula tireoide como maligna ou benigna